These are partially due to an anti-inflammatory through modulation of the IL-4, IL-8, IFN-γ and TNF-α cytokines in cancer cell lines, reducing expression of NF-κB and VEGF-1 as well as inducing cell death and/or apoptosis in a proportion of cancer cells. Here, CXCL8 is linked to cancer.